Detalhe da pesquisa
1.
Docetaxel plus gemcitabine or docetaxel plus cisplatin in advanced pancreatic carcinoma: randomized phase II study 40984 of the European Organisation for Research and Treatment of Cancer Gastrointestinal Group.
J Clin Oncol
; 23(36): 9250-6, 2005 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-16361622